Health
Who Makes Vaccine Policy Decisions in RFK Jr.’s Health Department?
For decades, as an activist, Robert F. Kennedy Jr. resisted the scientific consensus that vaccines are safe and necessary to prevent serious disease. Now at the helm of the nation’s health department, he has begun to put his extreme views into practice, ousting veteran scientists and installing allies across the nation’s health agencies to enact major shifts in vaccine policy.
Some of Mr. Kennedy’s hires are activists who have worked for years alongside him. Others are scientists who say they broadly support vaccines but publicly criticized Covid shots or mandates during the pandemic. Many of these scientists have begun to question the safety or value of other shots, reflecting the views of Mr. Kennedy. The following account is based on previous statements made by these officials and on interviews with current and former health agency leaders.
F.D.A. chief medical and scientific officer
Critical of Covid boosters and shots for healthy kids
F.D.A. commissioner
Skeptical of certain vaccines
Dr. Vinay Prasad
Dr. Marty Makary
The agency’s new vaccine lead and chief medical officer, Dr. Vinay Prasad, has called himself an “extreme pro-vaccine person,” and Dr. Marty Makary, the agency’s commissioner, said last week that “we believe in vaccines.”
But the two officials, who sharply criticized vaccine mandates as academic researchers during the pandemic, have expressed doubts about the safety and necessity of Covid boosters for healthy children and adults. This summer, Dr. Prasad overrode some agency scientists who favored widespread access to Covid shots, narrowing the vaccine’s eligibility to those 65 and older and to younger people with underlying medical conditions.
Last week, Dr. Makary echoed the views of Mr. Kennedy when he publicly questioned the longstanding recommendation to give the hepatitis B vaccine at birth. That shot is credited with nearly eliminating the transmission of the disease from mother to infant.
Dr. Prasad replaced a veteran at the agency, Dr. Peter Marks, who resigned in March and said that Mr. Kennedy’s aggressive stance on vaccines posed a danger to the public.
In June, Mr. Kennedy fired all 17 members of a powerful C.D.C. expert panel, the Advisory Committee on Immunization Practices. Insurance companies and government programs like Medicaid are required to cover the vaccinations that the panel recommends.
Mr. Kennedy handpicked eight new members that month, half of whom had expressed skepticism of vaccines at some point. (One has since stepped down.) Others have little expertise in immunology or vaccines.
On Monday, Mr. Kennedy appointed five more members, just days before the group meets to review recommendations for multiple vaccines. Some of the newly selected members have been critical of Covid vaccines or vaccine mandates.
Dr. Robert Malone is a controversial figure. He performed early experiments using mRNA in the 1980s but gained notoriety during the pandemic for claiming that Covid vaccines were unsafe, contradicting volumes of studies.
Martin Kulldorff, a biostatistician, has been generally supportive of vaccines but opposed Covid vaccination for children and vaccine mandates. Vicky Pebsworth, a nurse with a doctorate in public health, serves on the board of the National Vaccine Information Center, a nonprofit that disseminates misinformation about the risks of vaccination.
Dr. Malone and Dr. Kulldorff have served as paid expert witnesses in legal cases against vaccine makers. Dr. Pebsworth claimed in a lawsuit that a survey of families of unvaccinated children supported a hypothesis that a rise in the number of recommended childhood vaccines explained an epidemic of chronic disease.
Another panel member, Retsef Levi, is a management and health analytics expert at the Massachusetts Institute of Technology. He has been critical of a variety of vaccines and has called for Covid vaccines to be pulled from the market.
Dr. Evelyn Griffin, an obstetrician and gynecologist, questioned the safety and effectiveness of Covid vaccines in a hearing in the Louisiana House of Representatives in 2021. Dr. Kirk Milhoan, a pediatric cardiologist, questioned the safety and effectiveness of Covid vaccines at a 2024 event led by Representative Marjorie Taylor Greene, Republican of Georgia. Catherine M. Stein is an epidemiology professor who in 2022 called for an end to Covid vaccine mandates at universities.
Dr. Cody Meissner is a professor of pediatrics who opposed vaccine mandates and has questioned the ongoing need for Covid vaccines for children and pregnant women. He previously served on the advisory committee and is widely considered to be the most qualified member.
The others are not known to have spoken out against vaccines. They are Dr. Joseph R. Hibbeln, a nutritional neuroscientist; Dr. James Pagano, an emergency medicine physician; Hillary Blackburn, a pharmacist; and Dr. Raymond Pollak, a surgeon and transplant specialist.
The C.D.C. director has the power to accept or reject the immunization committee’s recommendations. The current acting director is Mr. Kennedy’s deputy at the Department of Health and Human Services, Jim O’Neill, a former biotechnology executive. The previous director, Susan Monarez, said she was forced out because she would not agree to accept the newly re-formed committee’s recommendations.
A special adviser to the C.D.C. director, Stuart Burns, is a critical player driving the health secretary’s agenda at the agency. Mr. Burns has been quietly working to remake the immunization committee and its agenda.
Mr. Burns is not a scientist but he worked for decades as a staff member for Republican congressmen known for their vaccine skepticism. One is Dr. Dave Weldon, a former representative from Florida who was also Mr. Kennedy’s original choice for C.D.C. director. The White House withdrew Dr. Weldon’s nomination just hours before his confirmation hearing because some Senate Republicans were concerned about his stance on vaccines.
Mr. Burns works closely with three other Kennedy hires who serve H.H.S. but also work closely with the C.D.C. Dr. Reyn Archer is a former Texas health commissioner who has questioned the safety and value of the Covid vaccine on social media. He serves as a liaison between the health secretary’s office and the C.D.C., and has been helping Mr. Burns to develop and guide the immunization committee.
David Geier is a steadfast figure in the anti-vaccine movement who has spent more than 20 years trying to establish a link between vaccines and autism, despite scientific consensus that there is none. Mr. Geier, who is listed as a senior data analyst in the H.H.S. directory, was given access to federal data on post-vaccination side effects and is using it to continue his studies on autism.
Lyn Redwood is a nurse practitioner and the former head of Children’s Health Defense, the anti-vaccine group founded by Mr. Kennedy. Since the early 2000s, Ms. Redwood has criticized the use of mercury as a preservative in vaccines. She has said she believes the ingredient is linked to her son’s autism.
Now listed as an expert at H.H.S., Ms. Redwood gave a presentation in June to the immunization committee, a role usually reserved for C.D.C. scientists. She said that the mercury preservative in vaccines, known as thimerosal, was toxic to children, even though dozens of studies have shown it is harmless in this form. The panel later voted to stop recommending the already limited number of flu vaccines that contained the preservative.
Principal deputy director of the N.I.H.
Skeptical of certain vaccines
N.I.H. director
Critical of Covid vaccine mandates
Dr. Matthew Memoli
Dr. Jay Bhattacharya
Dr. Matthew Memoli is a veteran infectious disease scientist at the National Institutes of Health who now serves as its principal deputy director. As a senior researcher under Dr. Anthony Fauci during the pandemic, Dr. Memoli opposed Covid vaccine mandates and declined to get a shot himself.
Since becoming a leader of the research agency, Dr. Memoli has downplayed the value of vaccines for certain respiratory diseases, according to the whistle-blower complaints of two prominent scientists.
Dr. Jay Bhattacharya, the N.I.H director, sharply criticized vaccine mandates as an academic researcher during the pandemic. He co-wrote an anti-lockdown treatise in 2020 with Dr. Kulldorff, one of Mr. Kennedy’s selections for the C.D.C. immunization committee.
During his confirmation hearing in March, Dr. Bhattacharya reiterated his support for childhood vaccinations for diseases like measles. He also said he was “convinced” vaccines did not cause autism, even as he urged more research on the question, which scientists say has long been settled.
Health
Hormone therapy boosts weight loss drug results by 35% in women, study finds
NEWYou can now listen to Fox News articles!
For women struggling with weight gain after menopause, a new study suggests that adding hormone therapy to a popular obesity drug may lead to greater weight loss.
Postmenopausal women lost about 35% more weight when using menopausal hormone therapy alongside tirzepatide — a GLP-1-based, Food and Drug Administration-approved drug for the overweight and obese — compared to those taking the drug alone, according to a Mayo Clinic study.
The findings, published in February in The Lancet Obstetrics, Gynaecology, & Women’s Health, highlight a possible new strategy for addressing weight gain after menopause, when hormonal shifts can increase the risk of obesity, cardiovascular disease and Type 2 diabetes.
STOPPING OZEMPIC? NEW STUDY REVEALS SURPRISING WEIGHT REGAIN RESULTS AFTER GLP-1S
“This study provides important insights for developing more effective and personalized strategies for managing cardiometabolic risk in postmenopausal women,” Dr. Regina Castaneda, the study’s first author, said in a statement.
A new study found that postmenopausal women lost more weight when combining hormone therapy with a GLP-1-based drug. (iStock)
Researchers analyzed 120 postmenopausal women who were overweight or obese who took tirzepatide for at least 12 months, including 40 who also used hormone therapy and 80 who did not.
Hormone therapy is commonly used to treat menopause symptoms like hot flashes and night sweats, while tirzepatide helps regulate appetite and blood sugar.
WEIGHT LOSS MEDICATIONS COULD IMPACT SEXUAL HEALTH IN UNEXPECTED WAYS
Women in the hormone therapy group lost an average of 19.2% of their body weight, compared to 14.0% in the non-hormone group — about 35% greater relative weight loss — with more women reaching significant weight-loss thresholds, according to the study.
Despite the results, researchers emphasized that the study was observational and cannot prove cause and effect.
Hormonal changes after menopause can increase weight gain and health risks. (iStock)
“Because this was not a randomized trial, we cannot say hormone therapy caused additional weight loss,” said Dr. Maria Daniela Hurtado Andrade, an endocrinologist at Mayo Clinic and senior author of the study.
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
Outside experts agree that the findings must be interpreted cautiously.
“As with all observational studies, we need to interpret this study with a grain of salt,” Dr. Gillian Goddard, a board-certified endocrinologist, told Fox News Digital.
Goddard, who is also an adjunct assistant professor of medicine at the NYU Grossman School of Medicine, noted that the findings show a link but do not prove that hormone therapy, which usually includes estrogen, directly caused the additional weight loss.
CLICK HERE FOR MORE HEALTH STORIES
“There may be important differences between the two groups,” she added. “For one thing, the group taking estrogen may be healthier than the groups that didn’t take estrogen. … Healthier people are more likely to eat a healthy diet and exercise in addition to taking tirzepatide. That could lead to more weight loss.”
Tirzepatide, a GLP-1-based drug, may be more effective for weight loss when paired with hormone therapy, according to researchers. (iStock)
Symptom relief from the therapy may have also improved sleep and well-being, making it easier for the group to maintain diet and exercise routines, Hurtado Andrade noted.
Researchers also pointed to a possible biological explanation. Preclinical data suggest estrogen may enhance the appetite-suppressing effects of GLP-1-based medications like tirzepatide, according to the study.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
Goddard said that theory is plausible but unproven.
Hormone therapy may ease menopause symptoms and help women stay on track with diet and exercise. (iStock)
“The other possibility is that estrogen interacts with tirzepatide in some way that makes it more potent,” she said. “We will need randomized studies to get a better handle on that.”
As for safety, experts say using the two together appears safe for most women. However, hormone therapy is not recommended for all patients, especially those with a history of certain cancers, blood clots or other underlying health risks, according to the Mayo Clinic.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
Researchers say future randomized trials will aim to confirm the findings and explore whether the combination also improves broader cardiometabolic health outcomes, according to the study.
Experts say more research is needed to confirm whether hormone therapy directly boosts weight loss results with GLP-1 drugs. (iStock)
“If confirmed, this work could speed the development and adoption of new, evidence-based strategies to reduce this risk for millions of postmenopausal women navigating this life stage,” Hurtado Andrade said.
Fox News Digital has reached out to the study authors for comment.
Health
The Best Belly Fat-Burning Foods That Shrink Your Waist up to 3X Faster
Use left and right arrow keys to navigate between menu items.
Use escape to exit the menu.
Sign Up
Create a free account to access exclusive content, play games, solve puzzles, test your pop-culture knowledge and receive special offers.
Already have an account? Login
Health
Most Americans are doing one nightly activity that’s wrecking their sleep, expert says
NEWYou can now listen to Fox News articles!
If you’re not sleeping well, there could be a variety of reasons, but one habit stands out as the biggest culprit.
Dr. Wendy Troxel, a licensed clinical psychologist and senior behavioral scientist at RAND based in Utah, revealed that phone use at night is the activity that is most likely to have a negative effect on slumber.
“Most people are aware of this, but probably the No. 1 habit that’s contributing to interrupted sleep and poor-quality sleep in Americans is the use of phones at night, particularly in bed,” she said in an interview with Fox News Digital.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
“About 90% of Americans are using their phones in bed, and as much as I would like to tell everybody to remove the phone entirely from the bedroom, I realize that ship has probably sailed by now.”
About 90% of Americans use their phones in bed, the sleep expert said. (iStock)
This disruption is driven by both blue light exposure and the stimulating content on phones, according to Troxel.
“There is blue light emitted from our devices, and blue light can suppress the hormone melatonin, which is the hormone of darkness.”
CLICK HERE FOR MORE HEALTH STORIES
“But it’s not just the blue light that is causing sleep disruptions from our phones. It’s really the stimulating content that we’re consuming … (on) social media, which is designed to be addictive, so that you can’t put that phone down,” she added.
The combination of blue light and stimulating content keeps the mind alert and interrupts quality sleep. (iStock)
This content is also “very emotionally activating,” Troxel noted, which is “antithetical to the state we want to be in as we approach sleep.”
To counteract attachment to phones, the sleep expert recommends setting a boundary with one simple rule.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
“I recommend that you try to keep your phone more than arms’ distance away from you while in bed,” she advised. “And set a rule for yourself. If you’re going to use the phone, don’t do it in bed. In fact, make your feet be on the floor if you’re going to use that phone.”
“I recommend that you try to keep your phone more than arms’ distance away from you while in bed,” the sleep expert recommended. (iStock)
Setting this boundary creates “behavioral friction,” according to Troxel.
“As a clinical psychologist, I work with people to help them … break habits that aren’t serving them,” she said. “Having that little bit of behavioral friction makes the habit of immediately grabbing for the phone and scrolling while in bed a little more difficult.
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
“And when that automatic behavior is a little more difficult, it’s less likely to occur.”
-
Sports1 week agoIOC addresses execution of 19-year-old Iranian wrestler Saleh Mohammadi
-
New Mexico6 days agoClovis shooting leaves one dead, four injured
-
Tennessee6 days agoTennessee Police Investigating Alleged Assault Involving ‘Reacher’ Star Alan Ritchson
-
Technology7 days agoYouTube job scam text: How to spot it fast
-
Minneapolis, MN3 days agoBoy who shielded classmate during school shooting receives Medal of Honor
-
Science1 week agoRecord Heat Meets a Major Snow Drought Across the West
-
Texas1 week agoHow to buy Houston vs. Texas A&M 2026 March Madness tickets
-
Politics1 week agoSchumer gambit fails as DHS shutdown hits 36 days and airport lines grow